PolTREG S.A. (PTG) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.154x

Based on the latest financial reports, PolTREG S.A. (PTG) has a cash flow conversion efficiency ratio of -0.154x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-7.63 Million ≈ $-2.10 Million USD) by net assets (zł49.48 Million ≈ $13.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of PolTREG S.A. to measure how many days the company can operate on defensive assets alone.

PolTREG S.A. - Cash Flow Conversion Efficiency Trend (2018–2024)

This chart illustrates how PolTREG S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

PolTREG S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PolTREG S.A. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Daesung Eltec Co. Ltd
KQ:025440
0.061x
Marti Otel Isletmeleri AS
IS:MARTI
-0.004x
Giyani Metals Corp
V:EMM
-0.058x
EDGE TOTAL INTELLIGENCE
F:Q5I
0.330x
Choo Bee Metal Industries Bhd
KLSE:5797
0.051x
Biotoxtech Co. Ltd
KQ:086040
-0.010x
Times Guaranty Limited
NSE:TIMESGTY
-0.017x
Kalyani Forge Limited
NSE:KALYANIFRG
-0.027x

Annual Cash Flow Conversion Efficiency for PolTREG S.A. (2018–2024)

The table below shows the annual cash flow conversion efficiency of PolTREG S.A. from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see PTG market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 zł69.23 Million
≈ $19.05 Million
zł-16.00 Million
≈ $-4.40 Million
-0.231x -52.30%
2023-12-31 zł87.52 Million
≈ $24.09 Million
zł-13.28 Million
≈ $-3.66 Million
-0.152x -78.29%
2022-12-31 zł101.04 Million
≈ $27.81 Million
zł-8.60 Million
≈ $-2.37 Million
-0.085x -128.55%
2021-12-31 zł103.01 Million
≈ $28.35 Million
zł-3.84 Million
≈ $-1.06 Million
-0.037x +82.85%
2020-12-31 zł12.83 Million
≈ $3.53 Million
zł-2.79 Million
≈ $-767.30K
-0.217x -100.11%
2019-12-31 zł-6.00K
≈ $-1.65K
zł-1.19 Million
≈ $-327.51K
198.333x +14627.96%
2018-12-31 zł764.00K
≈ $210.26K
zł-1.04 Million
≈ $-287.05K
-1.365x --

About PolTREG S.A.

WAR:PTG Poland Biotechnology
Market Cap
$24.13 Million
zł87.67 Million PLN
Market Cap Rank
#24520 Global
#239 in Poland
Share Price
zł18.80
Change (1 day)
+1.35%
52-Week Range
zł16.50 - zł33.70
All Time High
zł72.40
About

Poltreg S.A., a biotechnology company, researches and develops therapies for autoimmune diseases. It engages in the development of therapies for the treatment of type 1 diabetes in children, as well as multiple sclerosis. The company was incorporated in 2016 and is based in Gdansk, Poland.